During the past decade, Hospital Clinico, Pontificia Universidad Catolica de Chile conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 7 clinical trials were completed, i.e. on average, 140% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Clinico, Pontificia Universidad Catolica de Chile" #1 sponsor was "Pontificia Universidad Catolica de Chile" with 4 trials, followed by "Mannkind Corporation" with 2 trials sponsored, "MedImmune LLC" with 2 trials sponsored, "AO Clinical Investigation and Publishing Documentation" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Clinico, Pontificia Universidad Catolica de Chile" #1 collaborator was "Clínica UC San Carlos de Apoquindo." with 1 trials as a collaborator, "European Society of Anaesthesiology" with 1 trials as a collaborator, "Fondo Nacional de Desarrollo Científico y Tecnológico, Chile" with 1 trials as a collaborator and "Hospital Provicial Dr. Rafael Avaria Valenzuela" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Clinico, Pontificia Universidad Catolica de Chile" are "Respiratory Syncytial Virus Infections" (2 trials), "Acute Coronary Syndrome" (1 trials), "Aneurysmal Subarachnoid Hemorrhage" (1 trials), "Anxiety" (1 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "Hospital Clinico, Pontificia Universidad Catolica de Chile" in a lesser frequency.

Most popular intervention types in "Hospital Clinico, Pontificia Universidad Catolica de Chile" are "Drug" (9 trials), "Biological" (3 trials), "Other" (2 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "70% insulin aspart protamine suspension and 30% insulin aspart injection (rDNA origin)" (1 trials), "Ambrisentan" (1 trials), "BI 695500" (1 trials), "CPAP ventilation mode" (1 trials) and "Clazosentan 15 mg/h" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Clinico, Pontificia Universidad Catolica de Chile" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Clinico, Pontificia Universidad Catolica de Chile". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Hospital Clinico, Pontificia Universidad Catolica de Chile, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Clinico, Pontificia Universidad Catolica de Chile, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".

Hospital Clinico, Pontificia Universidad Catolica de Chile has several departments that took part in Clinical trials: "Instituto Nacional del Cáncer" - 19 trials